Glyphic Biotechnologies: Funding, Investors & Team (Oct 2026)
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
Glyphic Biotechnologies has raised $9.4M across 4 funding rounds on record, the most recent an undisclosed round of $100k announced in Apr 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Glyphic Biotechnologies Company Profile and Key Stats
Latest funding round on record: Apr 2023.
Glyphic Biotechnologies Funding Rounds
Glyphic Biotechnologies raised $6.0M in a Seed announced in Jul 2021.
9 months later, a Grant of $2.9M was announced in Apr 2022.
5 months later, a Grant of $410k was announced in Sep 2022.
7 months later, an undisclosed round of $100k was announced in Apr 2023.
Glyphic Biotechnologies Founders and Leadership Team
Contact details for the Glyphic Biotechnologies team: 1 of 2 have an email address on file.
Start 14-day free trial →Glyphic Biotechnologies Funding Compared to Other Biotechnology Startups
Glyphic Biotechnologies' latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Glyphic Biotechnologies in Biotechnology and New York
Companies Similar to Glyphic Biotechnologies
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Glyphic Biotechnologies Funding FAQs
What does Glyphic Biotechnologies do?
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
How much funding has Glyphic Biotechnologies raised?
Glyphic Biotechnologies has raised $9.4M across 4 rounds on record. The most recent is an undisclosed round of $100k announced in Apr 2023.
When did Glyphic Biotechnologies last raise funding?
Glyphic Biotechnologies' most recent funding round on record is an undisclosed round of $100k, announced in Apr 2023.
Who founded Glyphic Biotechnologies?
FundedIQ lists Daniel Estandian (Founder) at Glyphic Biotechnologies.
Who is the CEO of Glyphic Biotechnologies?
Joshua Yang is listed as CEO at Glyphic Biotechnologies.
Where is Glyphic Biotechnologies headquartered?
Glyphic Biotechnologies is based in New York, United States.
How many employees does Glyphic Biotechnologies have?
Glyphic Biotechnologies is in the 11-50 employee band.
How does Glyphic Biotechnologies' funding compare to other Biotechnology startups?
Glyphic Biotechnologies' latest round of $100k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Glyphic Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Glyphic Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.